Log In
BCIQ
Print this Print this
 

514G3

  Manage Alerts
Collapse Summary General Information
Company XBiotech Inc.
Description mAb against Staphylococcus aureus based on True Human technology
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationStaphylococcus
Indication DetailsTreat Staphylococcus aureus infection
Regulatory Designation U.S. - Fast Track (Treat Staphylococcus aureus infection)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today